Parkinson's disease patients' subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life

Neuropsychiatric Disease and Treatment

Volumn 8, Issue , 2012, Pages 435-442

  Skogar, Örjan ^a,d   Fall, Per Arne ^b   Hallgren, Gunnar ^c   Bringer, Birgitta ^b   Carlsson, Miriam ^a   Lennartsson, Ulla ^c   Sandbjörk, Håkan ^c   Törnhage, Carl Johan ^c   Lökk, Johan ^d  

^a RYHOV COUNTY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c SKARABORG HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Data reporting; Pain; Parkinson disease; Sleep fragmentation

Indexed keywords

ANXIOLYTIC AGENT; LEVODOPA; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ABNORMAL SENSATION; ADULT; AGED; ARTICLE; CHRONIC PAIN; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PARESTHESIA; PARKINSON DISEASE; POLYPHARMACY; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; SEX DIFFERENCE; SHORT FORM 36; SLEEP PATTERN; SLEEP QUALITY; SWEDEN; TRANSCUTANEOUS NERVE STIMULATION; URINARY URGENCY; VISUAL ANALOG SCALE;

EID: 84868139399     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S34882     Document Type: Article

References (37)

1. Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14(2):223-236.
2. Ford B. Pain in Parkinson's disease. Clin Neurosci. 1998;5(2): 63-72.
3. Beiske AG, Loge JH, Ronningen A, Svensson E. Pain in Parkinson's disease: Prevalence and characteristics. Pain. 2009;141(1-2): 173-177.
4. Bayulkem K, Lopez G. Clinical approach to nonmotor sensory fluctuations in Parkinson's disease. J Neurol Sci. 2011;310(1-2):82-85.
5. Giuffrida R, Vingerhoets FJ, Bogousslavsky J, Ghika J. Pain in Parkinson's disease. Rev Neurol (Paris). 2005;161(4):407-418. French.
6. Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology. 1976;26(5):423-439.
7. Defazio G, Berardelli A, Fabbrini G, etal. Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol. 2008;65(9):1191-1194.
8. Nègre-Pagès L, Regragui W, Bouhassira D, Grandiean H, Rascol O; for DoPaMiP Study Group. Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey. Mov Disord. 2008;23(10): 1361-1369.
9. Borgman A. Parkinsonenkät-98. Parkinsonjournalen. [study-overview]. 2002. Swedish.
10. Reid KJ, Harker J, Bala MM, etal. Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin. 2011;27(2):449-462.
11. Mylius V, Engau I, Teepker M, etal. Pain sensitivity and descending inhibition of pain in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2009;80(1):24-28.
12. Tison F, Wenning GK, Volonte MA, Poewe WR, Henry P, Quinn NP. Pain in multiple system atrophy. J Neurol. 1996;243(2):153-156.
13. Thorpy MJ. Sleep disorders in Parkinson's disease. Clin Cornerstone. 2004;6 Suppl 1A:S7-S15.
14. Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson's disease. Mov Disord. 2002;17(4):775-781.
15. Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol. 1988;11(6):512-519.
16. Partinen M. Sleep disorder related to Parkinson's disease. J Neurol. 1997;244(4 Suppl 1):S3-S6.
17. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord. 2008;23(10):1428-1434.
18. Quittenbaum BH, Grahn B. Quality of life and pain in Parkinson's disease: a controlled cross-sectional study. Parkinsonism Relat Disord. 2004;10(3):129-136.
19. Gibb WR, Lees AJ. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol. 1989;15(1):27-44.
20. Huskinson EC. Visual analogue scales. In: Melzack R, editor. Measurement and Assessment. New York, NY: Raven Press; 1983: 33-37.
21. Gaston-Johansson F. Measurement of pain: the psychometric properties of the Pain-O-Meter, a simple, inexpensive pain assessment tool that could change health care practices. J Pain Symptom Manage. 1996;12(3):172-181.
22. Chaudhuri KR, Pal S, DiMarco A, etal. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2002;73(6): 629-635.
23. Sullivan M, Karlsson J, Ware JE Jr. The Swedish SF-36 Health Survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995;41(10):1349-1358.
24. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003;18(7):738-750.
25. Goetz CG, Poewe W, Rascol O, etal; for Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004;19(9):1020-1028.
26. Crook J, Rideout E, Browne G. The prevalence of pain complaints in a general population. Pain. 1984;18(3):299-314.
27. Winkler J, Ehret R, Büttner T, etal. Parkinson's disease risk score: moving to a premotor diagnosis. J Neurol. 2011;258(Suppl 2): S311-S315.
28. Marinković Z, Kostić V, Coviković-Sternić N, Marinković S. Pain in patients with Parkinson disease. Srp Arh Celok Lek. 1990;118(11-12): 463-466. Serbian.
29. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord. 1986;1(1):45-49.
30. Bozi M, Bhatia KP. Paroxysmal exercise-induced dystonia as a presenting feature of young-onset Parkinson's disease. Mov Disord. 2003;18(12):1545-1547.
31. Jarcho JM, Mayer EA, Jiang ZK, Feier NA, London ED. Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain. 2012;153(4):744-754.
32. Boivie J. Pain in Parkinson's disease (PD). Pain. 2009;141(1-2):2-3.
33. van Hilten JJ, Weggeman M, van der Velde EA, Kerkhof GA, van Dijk JG, Roos RA. Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm Park Dis Dement Sect. 1993;5(3): 235-244.
34. Andersson K, Törnkvist L, Wändell P. Tactile massage within the primary health care setting. Complement Ther Clin Pract. 2009;15(3):158-160.
35. Lökk J, Nilsson M. Frequency, type and factors associated with the use of complementary and alternative medicine in patients with Parkinson's disease at a neurological outpatient clinic. Parkinsonism Relat Disord. 2010;16(8):540-544.
36. Sprigg N, Gray LJ, Bath PM, etal; for TAIST Investigators. Quality of life after ischemic stroke varies in western countries: data from the Tinzaparin in acute ischaemic stroke trial (TAIST). J Stroke Cerebrovasc Dis. March 10, 2011. [Epub before print.]
37. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord. 2010;25(15):2649-2653.